2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
|
|
- CAS番号.
- 134790-39-9
- 化学名:
- 别名:
- 英語名:
- 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
- 英語别名:
- Gemcitabine alpha-Anomer;2,2-DIFLOURO-2-DEOXYCYTIDINE-3,5-DIBENZOATE;2’,2’-Difluoro-2’-deoxycyodine-3’,5’-dibenzoate;(2R,3R,5R)-5-(4-aMino-2-oxopyriMidin-1(2H)-yl)-2-(benzoyloxyMethyl)-4,4-difluorotetrahydrofuran-3-yl benzoate;GCTB-T9;T9 of Gemcitabine;Chloropurine riboside;GeMcitabine InterMediate 9;Gemcitabine T9 Intermediate;(2R,3R,5R)-5-(4-amino-2-oxopyrimidin
- CBNumber:
- CB1855625
- 化学式:
- C23H19F2N3O6
- 分子量:
- 471.41
- MOL File:
- 134790-39-9.mol
|
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate 物理性質
- 融点 :
- 229-232°C
- 沸点 :
- 608.4±65.0 °C(Predicted)
- 比重(密度) :
- 1.45±0.1 g/cm3(Predicted)
- 貯蔵温度 :
- Sealed in dry,2-8°C
- 溶解性:
- DMSO
- 外見 :
- 個体
- 酸解離定数(Pka):
- 4.26±0.10(Predicted)
- 色:
- オフホワイト
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate 価格
もっと(7)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01MAS090818 |
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate |
134790-39-9 |
250mg |
¥341300 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01MAS090818 |
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate |
134790-39-9 |
1g |
¥757600 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCD232665 |
2'-Deoxy-3',5'-di-O-benzoyl-2',2'-difluorocytidine |
134790-39-9 |
100mg |
¥72000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCD232665 |
2'-Deoxy-3',5'-di-O-benzoyl-2',2'-difluorocytidine |
134790-39-9 |
1g |
¥137700 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCD232665 |
2'-Deoxy-3',5'-di-O-benzoyl-2',2'-difluorocytidine |
134790-39-9 |
2g |
¥154800 |
2023-06-01 |
購入 |
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate 化学特性,用途語,生産方法
化学的特性
Tan Solid
使用
A (-anomer) intermediate of Gemcitabine; antitumor compound
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate 上流と下流の製品情報
原材料
準備製品
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate 生産企業
Global( 185)Suppliers
134790-39-9()キーワード:
- 134790-39-9
- 2',2'-difluoro-2'-deoxycytidine-3',5'-dibenzoate
- Cytidine, 2'-deoxy-2',2'-difluoro-, 3',5'-dibenzoate
- 2'-Deoxy-3',5'-di-O-benzoyl-2',2'-difluorocytidine, >=97%
- 2-DEOXY-2,2-DIFLUORO-35-BIS-O-BENZOYLEYTIDINE MONOHYDROCHLORIDE
- T9 of Gemcitabine
- 2'-deoxy-2,2'-difluoro-3,5-dibenzyl-cytidine
- 2',2'-Difluoro-2'-deoxycyodine-3',5'–dibenzoate ( or its salt)
2'-deoxy-2',2'-difluoro-3',5'-di-O-benzoates-cytidine (or its salt)
- Cytidine, 2'-deoxy-2',2'-difluoro-, 3',5'-dibenzoate (9CI)
- 2’-Deoxy-2’,2’-difluoro-3’,5’-bis-O-benzoylcytidine
- 2’-Deoxy-3’,5’-di-O-benzoyl-2’,2’-difluorocytidine
- Chloropurine riboside
- 3',5'-Di-O-benzoyl-2'-deoxy-2',2'-difluorocytidine
- GeMcitabine InterMediate 9
- T9, 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
- 2'-Deoxy-2',2'-difluro-3'5'-bis-O-benzoylcytidine
- 2'-Deoxy-2',2'-difluorocytidine-3',5'-dibenzoate, 1-(3,5-Bis-O-benzoyl-2-deoxy-2,2-difluoro-beta-D-ribofuranosyl)cytosine
- 3',5'-Bis-O-benzoyl-2'-deoxy-2',2'-difluorocytidine
- [(2R,3S,5R)-5-(4-aMino-2-oxo-1,2-dihydropyriMidin-1-yl)-3-(benzoyloxy)-4,4-difluorooxolan-2-yl]Methyl benzoate
- 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (Gemcitabine impurity)
- 3',5'-Di-O-benzoyl-2',2'-difluoro-2'-deoxy cytidine
- (2R,3R,5R)-5-(4-amino-2-oxopyrimidin
- Gemcitabine impurity 4/2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
- 2-[[5-(4-amino-2-oxo-1-pyrimidinyl)-3-(2-carboxylatophenyl)-4,4-difluoro-3-hydroxy-2-oxolanyl]-hydroxymethyl]benzoate
- 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate USP/EP/BP
- (2R,3R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
- Gemcitabine T9 Intermediate
- (2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-(benzoyloxy)-4,4-difluorooxolan-2-yl]methyl benzoate
- 2’,2’-Difluoro-2’-deoxycyodine-3’,5’-dibenzoate
- (2R,3R,5R)-5-(4-aMino-2-oxopyriMidin-1(2H)-yl)-2-(benzoyloxyMethyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
- Gemcitabine alpha-Anomer